Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion type Assertion NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_head.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion wasGeneratedBy ECO_0000203 NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_provenance.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion wasDerivedFrom befree-20140225 NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_provenance.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion SIO_000772 17532523 NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_provenance.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion evidence source_evidence_literature NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_provenance.
- NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_assertion description "[To explore safety, pharmacokinetics, and pharmacodynamics of oral administration of resiquimod, a Toll-like receptor 7 and 8 agonist that induces endogenous interferon-alpha, in subjects with chronic hepatitis C virus infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207311.RAVGCQXCo9yQNk8Ov55YV1yTk4CaLtLj0YcN4QfC_OavE130_provenance.